Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Prepaid Assets (2019 - 2025)

Madrigal Pharmaceuticals (MDGL) has disclosed Prepaid Assets for 13 consecutive years, with $47.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Prepaid Assets rose 246.76% to $47.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $47.8 million, a 246.76% increase, with the full-year FY2025 number at $47.8 million, up 246.76% from a year prior.
  • Prepaid Assets was $47.8 million for Q4 2025 at Madrigal Pharmaceuticals, down from $49.3 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $58.6 million in Q2 2025 to a low of $822000.0 in Q1 2021.
  • A 5-year average of $13.6 million and a median of $3.5 million in 2021 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: decreased 20.46% in 2023, then soared 676.7% in 2024.
  • Madrigal Pharmaceuticals' Prepaid Assets stood at $1.3 million in 2021, then soared by 93.95% to $2.6 million in 2022, then grew by 21.39% to $3.2 million in 2023, then skyrocketed by 337.65% to $13.8 million in 2024, then surged by 246.76% to $47.8 million in 2025.
  • Per Business Quant, the three most recent readings for MDGL's Prepaid Assets are $47.8 million (Q4 2025), $49.3 million (Q3 2025), and $58.6 million (Q2 2025).